Holistic Dentists
- PRP Therapy
- Ozone Therapy
- Hormone Replacement Therapy (HRT)
- TMJ Treatment
- Stem Cell Therapy
New York City, NY
Stem-cell and orthobiologic rooms in New York City sit across Manhattan orthopedic towers, Brooklyn sports-med suites, Queens cash-pay longevity clinics, and academic medical campuses that still share one city label. Same phrase on the door. Different cell sources, same-day versus culture-expanded protocols, and consent forms. A Hoboken or Long Island commute changes who books follow-up imaging, not the product math. This hub is New York City NY listings.
Stem cell therapy is not one product. Tissue source, processing, who performs the injection, measured outcomes, and adverse-event handling all change what you buy. A lobby claim of "regenerative" is marketing until you see the written protocol.
This hub lists Directory clinics for New York City NY and stem cell therapy. Inclusion is not an endorsement. Listing order is not paid ranking. Regenerated.com is free for patients. Featured slots stay labeled; Verified means credential checks, not spend.
Ask what tissue or cell source they mean, whether the protocol is same-day or culture-expanded, who supervises care, what full cash-pay cost includes in writing, how adverse events are handled, and how claims connect to published evidence grades rather than borough slogans. Prefer plain risk talk and written consent. Use the national stem-cell Directory and Guide, then return here.
Before you trust badges or counts on this page, read How to read a Regenerated city hub and Featured vs Verified vs organic. Then return here for local listings.
Regulatory context
New York cellular therapy is governed by 21 CFR Part 1271. Section 361 covers minimally manipulated HCT/Ps used for homologous use without premarket approval. Section 351 covers products that are more than minimally manipulated, used non-homologously, or combined with another article, and these require an IND for clinical use or a BLA for marketing. Most stem cell, stromal vascular fraction, and exosome therapies marketed in New York for orthopedic, neurologic, and longevity indications are Section 351 biologics that lack FDA approval. New York also operates a parallel state-level tissue regulation framework through the Department of Health.
The FDA has issued warning letters to New York clinics offering stem cell and exosome therapies. The New York State Department of Health enforces additional tissue bank licensing requirements under 10 NYCRR Part 52, which means clinics handling HCT/Ps face dual federal and state inspection regimes. The Office of Professional Medical Conduct has disciplined physicians for unprofessional conduct including misleading regenerative medicine advertising. The New York Attorney General has used General Business Law Sections 349 and 350 to pursue stem cell clinics making unsupported clinical claims.
Available here
Nationwide
Stem Cell Therapy clinics across the US